The Indian Council of Medical Research (ICMR) licensed nine cutting-edge technologies to 17 industry partners under its Medical Innovations– Patent Mitra initiative, at Bharat Mandapam.

During the inaugural session of the India MedTech Expo 2025, the ceremony resulted in 17 licensing deals for innovations developed by various ICMR institutes in the areas of infectious disease diagnostics, immunodiagnostics, and vaccine development.

This milestone marks a significant step toward scaling indigenous medical technologies to reach the last mile and benefit public health across the nation. Senior officials from ICMR congratulated the scientists, innovators, and industry partners, noting that the initiative exemplifies how public research and private enterprise can work together to deliver high-quality, affordable, and homegrown medical innovations for every citizen. 

Technologies licensed during the ceremony included:

* Multistage Malaria Vaccine licensed to Indian Immunologicals Limited, Techinvention Lifecare Private Limited, Panacea Biotec Limited, Biological E Limited, and Zydus Lifesciences

* Diagnostic ELISA kits for the detection of IgM antibodies against Japanese Encephalitis virus, licensed to Diatek Healthcare Private Limited and Medsource Ozone Biomedicals Private Limited

* Diagnostic ELISA kits for the detection of IgM antibodies against Dengue virus, licensed to Diatek Healthcare Private Limited and Medsource Ozone Biomedicals Private Limited

* Diagnostic ELISA kits for the detection of IgM antibodies against Chikungunya virus, licensed to Diatek Healthcare Private Limited; Medsource Ozone Biomedicals Private Limited; and Matrix Labs Private Limited

* The AFuPEPLISA immunodiagnostic kit for detecting antibodies to Aspergillus fumigatus in patient sera, licensed to Medsource Ozone Biomedicals Private Limited

* A colorimetric isothermal (LAMP) assay for rapid detection of Monkeypox virus, licensed to SmartQR Technologies Private Limited

* A colorimetric RT-LAMP (isothermal) assay for rapid detection of Nipah virus, also licensed to SmartQR Technologies Private Limited

* A novel glycoconjugate Salmonella vaccine licensed to Biological E Limited

* A novel oral Shigella vaccine based on Multi-Serotype Outer Membrane Vesicles (MOMVs) licensed to Biological E Limited

This initiative ensures that life-saving tools developed through public research are available to communities across India. The manufacturing strength and distribution networks of industry partners will be instrumental in expanding the reach and impact of these technologies. This public-private partnership is a powerful catalyst for advancing India’s healthcare goals and plays a vital role in the journey toward achieving the vision of Viksit Bharat by 2047.

The event reaffirmed ICMR’s strong commitment to fostering innovation, strengthening intellectual property frameworks, and delivering advanced healthcare solutions through strategic public-private partnerships.

The India MedTech Expo 2025, taking place from 4th to 6th September 2025, provides a dynamic platform to showcase India’s growing leadership in the health and medical technology sectors, bringing together all the stakeholders, such as PLI participants, start-ups, MSMEs, innovative entrepreneurs, R&D facilities, incubators, as well as public and private hospitals.